Trial intelligence / Profile preview

[14C]-Estetrol Mass Balance Study

NCT02720224Phase 1Completed

Sponsor
Estetra SRL
Start
Feb 2016
Primary completion
Mar 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of estetrol in menopause and contraception, sponsored by Estetra SRL. Primary endpoint: Mass Balance of Total Radioactivity in Urine and Faeces. Started Feb 2016; status: completed.

02

Drugs

estetrol
03

Conditions

menopausecontraception

Beyond the preview

Go deeper on NCT02720224.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02720224.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call